INSPIRA TECH OXY IS-,125 Aktie Logo
IL0011715781
A3EZ7B
IINN

INSPIRA TECH OXY IS-,125 Aktie

Loading quotes...

Forecast

Buy
  1
Hold
  0
Sell
  0

  • Inspira Technologies wins $596,000 order for AME system from Irish research university

    Inspira Technologies has secured a $596,000 order for an AME system (additive manufacturing of electronics) from an Irish technological research university. The company received a non‑refundable 40% advance payment, with the remainder due on delivery. The order includes recurring revenue from consumables, wear parts and annual service fees; delivery, installation and training are planned in the coming weeks and are intended to serve as a reference for further academic and commercial collaborations in Europe. Inspira has a market capitalization of $19.28 million and annual revenue of $290,000. » More on de.investing.com


  • Inspira Technologies enters quantum computing and plans to rebrand as QTREX

    Inspira Technologies announces a strategic entry into the quantum computing sector and aims to use its additively manufactured AME platform to address 3D connectivity issues in dilution cryostats to improve qubit coherence and system stability. The company, led by CEO Dagi Ben-Noon and COO Avi Shabtay, reports a proof of concept for integrating qubit-relevant components and is negotiating partnerships but provides no details or timelines. Inspira plans to continue its medical technology division as a subsidiary, intends to change its name to QTREX, and points to large market forecasts, but remains financially unprofitable and shows high cash outflows. » More on de.investing.com


  • Inspira Technologies terminates two financing agreements

    Inspira Technologies announces the written termination of its sales agreement with A.G.P./Alliance Global Partners dated 17 February 2026 and its standby equity purchase agreement with YA II PN, Ltd. dated 12 December 2025. The company has no outstanding obligations under either agreement and no further payments will be made. Inspira cites the goal of a disciplined capital structure as the reason for the move while it prepares for the next strategic phase; the stock has recently fallen sharply and, according to InvestingPro, is fairly valued. » More on de.investing.com

Financials

In the last quarter, INSPIRA TECH OXY IS-,125 Aktie had revenue of €122.6K and net profit of -€2.71M
(EUR) June 2025
YoY
Revenue 122.6K -
Gross profit 848.42 -
Net profit -2.71M -
EBITDA -3.04M -

Fundamentals

Metric Value
Market capitalization
€22.55M
Number of shares
24.08M
52-week high/low
€1.87 - €0.30
Dividends No
Beta
2.33
P/E ratio
-
PEG ratio
-
P/B ratio
-
P/S ratio
-

Company profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

Name
INSPIRA TECH OXY IS-,125 Aktie
CEO
Dagi Shahar Ben-Noon
Headquarters Ra'anana,
Israel
Website
Sector
Consumer Discretionary
Industry
Household Durables
IPO
07/14/2021
Employees 39

Ticker symbols

Exchange Symbol
NASDAQ
IINN
🍪

Parqet  uses cookies. Learn more